ReviewInternational journal of molecular sciences2022

The Future of Targeted Treatment of Primary Sjögren's Syndrome: A Focus on Extra-Glandular Pathology.

Weizhen Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.